Equity Analysis /
United States of America

US : Pharmaceuticals - Specialty Pharmaceuticals | U.S. RX Volumes Continue Steady March to Pre-COVID Norms Led by Improving New Therapy Starts

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    31 August 2021
    Published by